Evidence map›Paper›PMID 24417915›Full record

ReviewBiotechnology advances

Decellularized tissue and cell-derived extracellular matrices as scaffolds for orthopaedic tissue engineering.

Christina W Cheng, Loran D Solorio, Eben Alsberg

Abstract readReview
In one paragraph

Review in Biotechnology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 150 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
150citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

150 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

90 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christina W ChengDepartment of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Avenue, Wickenden Building, Rm 218, Cleveland, OH, USA; Department of Orthopaedic Surgery, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH, USA. Electronic address: chengcw@gmail.com.
Loran D SolorioDepartment of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Avenue, Wickenden Building, Rm 218, Cleveland, OH, USA. Electronic address: loran.solorio@gmail.com.
Eben AlsbergDepartment of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Avenue, Wickenden Building, Rm 218, Cleveland, OH, USA; Department of Orthopaedic Surgery, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH, USA; National Center for Regenerative Medicine, Division of General Medical Sciences, Case Western Reserve University, Cleveland, OH, USA. Electronic address: eben.alsberg@case.edu.

Funding

TRAINING PROGRAM IN MUSCULOSKELETAL RESEARCHT32AR007505 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI TRIOLO, RONALD J · 1986 to 2023
$6.3M
Driving Tissue Formation by Inductive Stem Cell Sheet TechnologyR01AR063194 · NIAMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ALSBERG, EBEN · 2012 to 2016
$1.7M
Growth Plate RegenerationR21AR061265 · NIAMS · CLEVELAND CLINIC LERNER COM-CWRU · PI ALSBERG, EBEN, BALLOCK, ROBERT TRACY · 2012 to 2013
$392k
Controlled, Sustained Delivery of siRNA to hMSCs for Enhanced Bone RegenerationR56DE022376 · NIDCR · CASE WESTERN RESERVE UNIVERSITY · PI ALSBERG, EBEN · 2012 to 2012
$346k
NIAMS NIH HHS R01 AR063194NIAMS NIH HHS R01AR063194NIAMS NIH HHS R21 AR061265NIAMS NIH HHS R21AR061265NIAMS NIH HHS T32 AR007505NIAMS NIH HHS T32AR007505NIDCR NIH HHS R56 DE022376NIDCR NIH HHS R56DE022376
6 · The paper itself

Abstract

The reconstruction of musculoskeletal defects is a constant challenge for orthopaedic surgeons. Musculoskeletal injuries such as fractures, chondral lesions, infections and tumor debulking can often lead to large tissue voids requiring reconstruction with tissue grafts. Autografts are currently the gold standard in orthopaedic tissue reconstruction; however, there is a limit to the amount of tissue that can be harvested before compromising the donor site. Tissue engineering strategies using allogeneic or xenogeneic decellularized bone, cartilage, skeletal muscle, tendon and ligament have emerged as promising potential alternative treatment. The extracellular matrix provides a natural scaffold for cell attachment, proliferation and differentiation. Decellularization of in vitro cell-derived matrices can also enable the generation of autologous constructs from tissue specific cells or progenitor cells. Although decellularized bone tissue is widely used clinically in orthopaedic applications, the exciting potential of decellularized cartilage, skeletal muscle, tendon and ligament cell-derived matrices has only recently begun to be explored for ultimate translation to the orthopaedic clinic.

Indexed as

Extracellular MatrixMusculoskeletal SystemTissue EngineeringTissue ScaffoldsAnimalsHumansMiceStem CellsSwineArticular cartilageBoneDecellularized matrixExtracellular matrixLigamentsSkeletal muscleTendonsTissue engineeringTissue scaffolds

Identifiers

PMID24417915
PMCPMC3959761

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.